Skip to content

Quantum QSOR (REF 51-000074-00)Recalls & reported problems

Spectrum Medical Limited · Quantum Smart Occluder - Right Hand · Class 2

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 05060434421944), received between Dec 9, 2024 and Feb 12, 2026 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Activation Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Activation Failure1
  • Obstruction of Flow1
  • Unintended Movement1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 12, 2026Unintended Movement

    THE CUSTOMER REPORTED A SUDDEN LOCKING OF THE VENOUS OCCLUDER; AND THAT OPENING THE OCCLUDER WAS NOT POSSIBLE. THE CUSTOMER HAD TO OPEN THE OCCLUDE IN A MANUAL WAY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24320428 ↗
  • MalfunctionJan 29, 2025Activation Failure; Activation Failure

    LOANER OCCLUDER THAT WAS SENT IN RESPONSE TO FON #(B)(6) STOPPED RESPONDING TO OPEN/CLOSE COMMANDS FROM THE QWS. REPORTEES ARE UNSURE IF THERE WAS A "NO OCCLUDER LOCATION" MESSAGE AT THE TIME OF THIS EVENT. THE OCCLUDER WAS ALSO REPORTED TO "EVENTUALLY START WORKING" AGAIN. ISSUE OCCURED APPROX. 1000 PRIOR TO A CASE. RECOMMENDATION WAS GIVEN TO TRY A NEW CABLE AND THEN A NEW PORT ON THE FRAME IF THE CABLE WAS DAMAGED FROM THE FRAME. NO FURTHER INFORMATION. SAME REP CONTACTED AGAIN AROUND 1700 STATING AS BIOMED ATTEMPTED TO DOWNLOAD LOGS FOR THE ISSUE ABOVE, ONLY THE QWS WOULD BOOT UP AND NOT THE REST OF THE SUBMODULES. REST OF THE PUMP WAS TURNED ON VIA THE SOLARIS POWER BUTTON BUT PUMP MANAGER WAS NOT PRESENT. SAP CABLE WAS UNPLUGGED FROM THE QWS AND REPLUGGED IN BUT PUMP MANAGER WAS STILL NOT PRESENT. QWS WAS THEN TURNED OFF WITH A LONG PRESS, THEN SAP CABLE UNPLUGGED AGAIN AND REPLUGGED IN. UPON BOOT UP PUMP MANAGER CAME BACK. MEDTRONIC REP WAS ON FACETIME WITH BIOMED AND VERIFIES THAT SOLARIS WAS PLUGGED INTO THE WALL DURING THIS TIME. HE ALSO SENT A PICTURE OF A QWS WITH A GREEN POWER LED IN THE BOTTOM RIGHT INSTEAD OF BLINKING BLUE, SUGGESTING THAT THE HLM WAS PLUGGED INTO TH

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21264089 ↗
  • MalfunctionDec 9, 2024Obstruction of Flow; Obstruction of Flow

    VENOUS OCCLUDER ENGAGED DURING A CASE WITH A PATIENT WHEN NOT ACTIVATED. PERFUSIONIST MANUALLY RELEASED THE CLAMP. THERE WAS NO PATIENT HARM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20878470 ↗

Other Console, Heart-Lung Machine, Cardiopulmonary Bypass devices

All Console, Heart-Lung Machine, Cardiopulmonary Bypass devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.